These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The diagnosis and treatment of minimal hepatic encephalopathy. Zhan T; Stremmel W Dtsch Arztebl Int; 2012 Mar; 109(10):180-7. PubMed ID: 22470407 [TBL] [Abstract][Full Text] [Related]
14. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Rivera Ramos JF; RodrÃguez Leal C Ann Hepatol; 2011 Jun; 10 Suppl 2():S36-9. PubMed ID: 22228879 [TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Huang E; Esrailian E; Spiegel BM Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure. Kodali S; McGuire BM Clin Liver Dis; 2015 Aug; 19(3):565-76. PubMed ID: 26195209 [TBL] [Abstract][Full Text] [Related]
18. Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain. Congly SE; Leise MD Am J Gastroenterol; 2014 Apr; 109(4):598. PubMed ID: 24698864 [No Abstract] [Full Text] [Related]
19. Response to Congly and Leise. Praveen S; Chander SB Am J Gastroenterol; 2014 Apr; 109(4):598-9. PubMed ID: 24698865 [No Abstract] [Full Text] [Related]